Camille Gunderson Jackson

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium”.

A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.04.016

N/A

0DataRank · unranked

19 citations

Kathleen N. Moore, Leigh A. Cantrell, Britt Erickson, Linda Duska, Debra L. Richardson +10 more

Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.08.005

N/A

0DataRank · unranked

10 citations

Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille Gunderson Jackson, Casey Cosgrove +14 more